Our study found that altered CIC in glioma was associated with better cognitive status; this raises the question of whether mutations in CIC affect the function of the CIC-ATXN1 complex, thereby inhibiting its neurotoxic effects. Here, ATXN1 is linked to central nervous system cancer.